Free Float 54,77 %
Shares Float 24,31 M
Shares Outstanding 44,39 M
DongKook Pharmaceutical Co., Ltd.
Share · KR7086450004 (XKOS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of DongKook Pharmaceutical Co., Ltd.
No Price
Closing Price XKOS 29.04.2026:
24.600,00 KRW
29.04.2026 06:30
Current Prices from DongKook Pharmaceutical Co., Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 KOSDAQ |
086450.KQ
|
KRW
|
29.04.2026 06:30
|
24.600,00 KRW
| -300,00 KRW
-1,20 %
|
Share Float & Liquidity
Invested Funds
The following funds have invested in DongKook Pharmaceutical Co., Ltd.:
Fund | Vol. in million 65,84 | Percentage (%) 0,06 % |
Company Profile for DongKook Pharmaceutical Co., Ltd. Share
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
Company Data
Name DongKook Pharmaceutical Co., Ltd.
Company DongKook Pharmaceutical Co., Ltd.
Website
https://www.dkpharm.co.kr
Primary Exchange
KOSDAQ
KOSDAQ
ISIN KR7086450004
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Heung-Ju Oh
Market Capitalization 1.105 Mrd.
Country South Korea
Currency KRW
Employees 1,1 T
Address 7, Teheran-ro 108-gil, Seoul
IPO Date 2007-05-29
Dividends from 'DongKook Pharmaceutical Co., Ltd.'
| Ex-Date | Dividend per Share |
|---|---|
| 29.12.2025 | 200,00 KRW |
| 27.12.2024 | 200,00 KRW |
| 27.12.2023 | 180,00 KRW |
| 28.12.2022 | 180,00 KRW |
| 28.12.2016 | 2.000,00 KRW |
| 29.12.2015 | 1.500,00 KRW |
| 29.12.2014 | 1.500,00 KRW |
| 27.12.2013 | 1.400,00 KRW |
| 27.12.2012 | 1.900,00 KRW |
| 28.12.2011 | 1.900,00 KRW |
Stock Splits
| Date | Split |
|---|---|
| 24.08.2020 | 5:1 |
| 25.06.2009 | 13:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| KOSDAQ | 086450.KQ |
More Shares
Investors who hold DongKook Pharmaceutical Co., Ltd. also have the following shares in their portfolio:
